Applications
Rules-Based Medicine provides a biomarker patterning service to pharma, biotech, contract research organizations and consumer product companies as well as academic, government and institutional laboratories. These patterns are produced using comprehensive, quantitative immunoassay panels that provide robust data for drug discovery, diagnostic, environmental and research applications. This service is cost-effective and uses a small sample. RBM is CLIA certified and supports GLP studies.